{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:29:44Z","timestamp":1795008584352,"version":"4.9.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Herzzentrum G\u00f6ttingen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Pressure overload first leads to compensated hypertrophy and secondary to heart failure. m6A-RNA methylation is a fast process for the adaptation of cell composition. m6A-RNA-methylation is regulated by the demethylase, fat mass and obesity-associated protein\n                      <jats:italic>(<\/jats:italic>\n                      FTO), and FTO protein levels are diminished in heart failure. Cardiomyocyte-specific FTO-transgenic\/knockout-mice have shown the relevance of FTO in pressure overload remodeling. However, its functional downstream regulatory mechanisms are still unclear. In this study, we discover the harmful signaling pathways that are triggered by m6A imbalance and FTO loss, which eventually lead to adverse cardiac remodeling and heart failure.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      FTOcKO animals were generated by crossing FTO\n                      <jats:sup>fl\/fl<\/jats:sup>\n                      mice with\n                      <jats:inline-formula>\n                        <jats:tex-math>$$\\alpha$$<\/jats:tex-math>\n                      <\/jats:inline-formula>\n                      -\n                      <jats:italic>MHC<\/jats:italic>\n                      Cre mice using Cre-lox system. Control and the FTOcKO animals groups were subjected to TAC (transverse aortic constriction) surgery. Echocardiography was performed 1-week post-TAC surgery. MeRIP (m6A RNA immunoprecipitation) sequencing was performed from the heart tissues of mice after one week TAC surgery. Additionally, the mechanistical interrelation between the signaling pathways during FTO loss and adverse cardiac remodeling were investigated in human iPS-CMs (hiPS-CMs).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      One week post-TAC surgery, FTOcKO mice showed impaired cardiac function (EF: CreC TAC (45%) vs. FTOcKO TAC (25%),\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001) and increased LVID (CreC TAC(3.9\u00a0mm) vs. FTOcKO TAC (4.8\u00a0mm),\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001), indicating a lack of adaption to pressure overload. Knockdown of FTO in hiPS-cardiomyocytes also reduced endothelin-induced hypertrophic response.\n                    <\/jats:p>\n                    <jats:p>MeRIP-seq data of FTOcKO mice showed that the differentially hypermethylated transcripts were associated with cardiac apoptosis inhibition (CDK1, CFLAR), mTORC1 signaling pathway (AKT1S1) and autophagy regulation (TFEB). mTORC1 was identified as a central player of dysregulation with hyperactivation of its canonical substrates phospho-S6K1 (Thr 389) and phospho-S6 (ser235\/236) ex-vivo (FTOcKO) and in-vitro (FTO-KD-hiPS-CMs).<\/jats:p>\n                    <jats:p>Moreover, FTO-deficient cardiomyocytes cause autophagic flux impairment and defective autophagy. The effect of atrophy and induced apoptosis upon FTO-m6A imbalance could be rescued by pharmacological inhibiton of the mTORC1-S6K1 pathway.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Downregulation of FTO leads to mTORC1-S6K1 hyperactivation that shift the compensative hypertrophic response to atrophy and apoptosis leading to progressive heart failure. These findings might pave the way for the development of novel therapeutic targets for the early phases of heart failure treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12964-025-02509-0","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T01:23:32Z","timestamp":1764638612000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Deregulation of m6A-RNA methylation impairs adaptive hypertrophic response and drives maladaptation via mTORC1-S6K1-hyperactivation and autophagy impairment"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7558-8035","authenticated-orcid":false,"given":"Karthika","family":"Annamalai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5118-6908","authenticated-orcid":false,"given":"Soniya","family":"Dilliker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Buchholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Castro-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5224-131X","authenticated-orcid":false,"given":"Nikita","family":"Panyam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessa","family":"Pommeranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Wiederhake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Wery von Limont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Hempel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Ebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surabhi","family":"Swarnkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belal A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5137-7228","authenticated-orcid":false,"given":"Katrin","family":"Streckfuss-B\u00f6meke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6892-9751","authenticated-orcid":false,"given":"Sabine","family":"Steffens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Herzig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3642-242X","authenticated-orcid":false,"given":"Antje","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8546-1161","authenticated-orcid":false,"given":"Andre","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Toischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"2509_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fphys.2020.00092","volume":"11","author":"FG Pitoulis","year":"2020","unstructured":"Pitoulis FG, Terracciano CM. Heart plasticity in response to pressure- and volume-overload: a review of findings in compensated and decompensated phenotypes. Front Physiol. 2020;11:92.","journal-title":"Front Physiol"},{"key":"2509_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","volume":"97","author":"I Shimizu","year":"2016","unstructured":"Shimizu I, Minamino T. Physiological and pathological cardiac hypertrophy. J Mol Cell Cardiol. 2016;97:245\u201362.","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"2509_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1139\/cjpp-2019-0566","volume":"98","author":"CJ Oldfield","year":"2020","unstructured":"Oldfield CJ, Duhamel TA, Dhalla NS. Mechanisms for the transition from physiological to pathological cardiac hypertrophy. Can J Physiol Pharmacol. 2020;98(2):74\u201384.","journal-title":"Can J Physiol Pharmacol"},{"issue":"7","key":"2509_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 2018;15(7):387\u2013407.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"2509_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1161\/CIRCULATIONAHA.118.036146","volume":"139","author":"LE Dorn","year":"2019","unstructured":"Dorn LE, Lasman L, Chen J, Xu X, Hund TJ, Medvedovic M, et al. The N(6)-methyladenosine mRNA methylase METTL3 controls cardiac homeostasis and hypertrophy. Circulation. 2019;139(4):533\u201345.","journal-title":"Circulation"},{"key":"2509_CR6","doi-asserted-by":"publisher","first-page":"887838","DOI":"10.3389\/fcvm.2022.887838","volume":"9","author":"C Liu","year":"2022","unstructured":"Liu C, Gu L, Deng W, Meng Q, Li N, Dai G, et al. N6-methyladenosine RNA methylation in cardiovascular diseases. Front Cardiovasc Med. 2022;9:887838.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"2509_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-020-01224-3","volume":"19","author":"L Zhang","year":"2020","unstructured":"Zhang L, Hou C, Chen C, Guo Y, Yuan W, Yin D, et al. The role of N(6)-methyladenosine (m(6)A) modification in the regulation of circRNAs. Mol Cancer. 2020;19(1):105.","journal-title":"Mol Cancer"},{"issue":"7","key":"2509_CR8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1631\/jzus.B1900680","volume":"21","author":"K Zhao","year":"2020","unstructured":"Zhao K, Yang CX, Li P, Sun W, Kong XQ. Epigenetic role of N6-methyladenosine (m6A) RNA methylation in the cardiovascular system. J Zhejiang Univ Sci B. 2020;21(7):509\u201323.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"7397","key":"2509_CR9","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11112","volume":"485","author":"D Dominissini","year":"2012","unstructured":"Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485(7397):201\u20136.","journal-title":"Nature"},{"key":"2509_CR10","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3389\/fimmu.2019.00922","volume":"10","author":"C Zhang","year":"2019","unstructured":"Zhang C, Fu J, Zhou Y. A review in research progress concerning m6A methylation and immunoregulation. Front Immunol. 2019;10:922.","journal-title":"Front Immunol"},{"issue":"3","key":"2509_CR11","doi-asserted-by":"publisher","first-page":"e105977","DOI":"10.15252\/embj.2020105977","volume":"40","author":"PC He","year":"2021","unstructured":"He PC, He C. M(6) a RNA methylation: from mechanisms to therapeutic potential. EMBO J. 2021;40(3):e105977.","journal-title":"EMBO J"},{"key":"2509_CR12","doi-asserted-by":"publisher","first-page":"635329","DOI":"10.3389\/fonc.2021.635329","volume":"11","author":"XY Dai","year":"2021","unstructured":"Dai XY, Shi L, Li Z, Yang HY, Wei JF, Ding Q. Main N6-methyladenosine readers: YTH family proteins in cancers. Front Oncol. 2021;11:635329.","journal-title":"Front Oncol"},{"issue":"7574","key":"2509_CR13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nature15377","volume":"526","author":"J Zhou","year":"2015","unstructured":"Zhou J, Wan J, Gao X, Zhang X, Jaffrey SR, Qian SB. Dynamic m(6)A mRNA methylation directs translational control of heat shock response. Nature. 2015;526(7574):591\u20134.","journal-title":"Nature"},{"issue":"1","key":"2509_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/ejhf.1672","volume":"22","author":"T Berulava","year":"2020","unstructured":"Berulava T, Buchholz E, Elerdashvili V, Pena T, Islam MR, Lbik D, et al. Changes in m6A RNA methylation contribute to heart failure progression by modulating translation. Eur J Heart Fail. 2020;22(1):54\u201366.","journal-title":"Eur J Heart Fail"},{"key":"2509_CR15","doi-asserted-by":"crossref","unstructured":"Fernandez Rodriguez G, Cesaro B, Fatica A. Multiple roles of m6A RNA modification in translational regulation in cancer. Int J Mol Sci. 2022;23(16):8971.","DOI":"10.3390\/ijms23168971"},{"key":"2509_CR16","doi-asserted-by":"crossref","unstructured":"Kmietczyk V, Riechert E, Kalinski L, Boileau E, Malovrh E, Malone B, et al. m(6)A-mRNA methylation regulates cardiac gene expression and cellular growth. Life Sci Alliance. 2019;2(2):e201800233.","DOI":"10.26508\/lsa.201800233"},{"issue":"4","key":"2509_CR17","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1161\/CIRCULATIONAHA.118.033794","volume":"139","author":"P Mathiyalagan","year":"2019","unstructured":"Mathiyalagan P, Adamiak M, Mayourian J, Sassi Y, Liang Y, Agarwal N, et al. FTO-dependent n(6)-methyladenosine regulates cardiac function during remodeling and repair. Circulation. 2019;139(4):518\u201332.","journal-title":"Circulation"},{"issue":"9","key":"2509_CR18","doi-asserted-by":"publisher","first-page":"e2204933120","DOI":"10.1073\/pnas.2204933120","volume":"120","author":"R Castro-Hernandez","year":"2023","unstructured":"Castro-Hernandez R, Berulava T, Metelova M, Epple R, Pena Centeno T, Richter J, et al. Conserved reduction of m(6)A RNA modifications during aging and neurodegeneration is linked to changes in synaptic transcripts. Proc Natl Acad Sci U S A. 2023;120(9):e2204933120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2509_CR19","doi-asserted-by":"publisher","first-page":"892113","DOI":"10.3389\/fcvm.2022.892113","volume":"9","author":"S Fan","year":"2022","unstructured":"Fan S, Hu Y. Role of m6A methylation in the occurrence and development of heart failure. Front Cardiovasc Med. 2022;9:892113.","journal-title":"Front Cardiovasc Med"},{"key":"2509_CR20","doi-asserted-by":"crossref","unstructured":"Xu ZY, Jing X, Xiong XD. Emerging role and mechanism of the FTO gene in cardiovascular diseases. Biomolecules. 2023;13(5):850.","DOI":"10.3390\/biom13050850"},{"issue":"3","key":"2509_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1161\/CIRCRESAHA.117.311147","volume":"122","author":"S Sciarretta","year":"2018","unstructured":"Sciarretta S, Forte M, Frati G, Sadoshima J. New insights into the role of mTOR signaling in the cardiovascular system. Circ Res. 2018;122(3):489\u2013505.","journal-title":"Circ Res"},{"issue":"3","key":"2509_CR22","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/CIRCRESAHA.114.302022","volume":"114","author":"S Sciarretta","year":"2014","unstructured":"Sciarretta S, Volpe M, Sadoshima J. Mammalian target of rapamycin signaling in cardiac physiology and disease. Circ Res. 2014;114(3):549\u201364.","journal-title":"Circ Res"},{"issue":"10","key":"2509_CR23","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1161\/CIRCULATIONAHA.110.977066","volume":"123","author":"P Shende","year":"2011","unstructured":"Shende P, Plaisance I, Morandi C, Pellieux C, Berthonneche C, Zorzato F, et al. Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice. Circulation. 2011;123(10):1073\u201382.","journal-title":"Circulation"},{"issue":"1","key":"2509_CR24","doi-asserted-by":"publisher","first-page":"100026","DOI":"10.1016\/j.xpro.2020.100026","volume":"1","author":"M Kleinsorge","year":"2020","unstructured":"Kleinsorge M, Cyganek L. Subtype-directed differentiation of human iPSCs into atrial and ventricular cardiomyocytes. STAR Protoc. 2020;1(1):100026.","journal-title":"STAR Protoc"},{"key":"2509_CR25","doi-asserted-by":"publisher","first-page":"702579","DOI":"10.3389\/fcell.2021.702579","volume":"9","author":"W Ju","year":"2021","unstructured":"Ju W, Liu K, Ouyang S, Liu Z, He F, Wu J. Changes in N6-methyladenosine modification modulate diabetic cardiomyopathy by reducing myocardial fibrosis and myocyte hypertrophy. Front Cell Dev Biol. 2021;9:702579.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"2509_CR26","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s12015-022-10485-y","volume":"19","author":"C Tian","year":"2023","unstructured":"Tian C, An Y, Zhao J, Zhu X, Wei W, Ruan G, et al. Bone marrow mesenchymal stem cells reversed ovarian aging-related m6A RNA methylation modification profile in aged granulosa cells. Stem Cell Rev Rep. 2023;19(4):953\u201367.","journal-title":"Stem Cell Rev Rep"},{"issue":"1","key":"2509_CR27","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13148-023-01602-w","volume":"15","author":"R Yu","year":"2023","unstructured":"Yu R, Yu Q, Li Z, Li J, Yang J, Hu Y, et al. Transcriptome-wide map of N6-methyladenosine (m6A) profiling in coronary artery disease (CAD) with clopidogrel resistance. Clin Epigenetics. 2023;15(1):194.","journal-title":"Clin Epigenetics"},{"issue":"7700","key":"2509_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41586-018-0016-3","volume":"556","author":"K Ronaldson-Bouchard","year":"2018","unstructured":"Ronaldson-Bouchard K, Ma SP, Yeager K, Chen T, Song L, Sirabella D, et al. Advanced maturation of human cardiac tissue grown from pluripotent stem cells. Nature. 2018;556(7700):239\u201343.","journal-title":"Nature"},{"issue":"4","key":"2509_CR29","doi-asserted-by":"publisher","first-page":"100052","DOI":"10.1016\/j.xcrm.2020.100052","volume":"1","author":"A Sharma","year":"2020","unstructured":"Sharma A, Garcia G Jr., Wang Y, Plummer JT, Morizono K, Arumugaswami V, et al. Human iPSC-derived cardiomyocytes are susceptible to SARS-CoV-2 infection. Cell Rep Med. 2020;1(4):100052.","journal-title":"Cell Rep Med"},{"issue":"10","key":"2509_CR30","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1161\/CIRCULATIONAHA.110.943431","volume":"122","author":"K Toischer","year":"2010","unstructured":"Toischer K, Rokita AG, Unsold B, Zhu W, Kararigas G, Sossalla S, et al. Differential cardiac remodeling in preload versus afterload. Circulation. 2010;122(10):993\u20131003.","journal-title":"Circulation"},{"key":"2509_CR31","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.yjmcc.2019.12.002","volume":"138","author":"MJ Baier","year":"2020","unstructured":"Baier MJ, Klatt S, Hammer KP, Maier LS, Rokita AG. Ca(2+)\/calmodulin-dependent protein kinase II is essential in hyperacute pressure overload. J Mol Cell Cardiol. 2020;138:212\u201321.","journal-title":"J Mol Cell Cardiol"},{"issue":"9","key":"2509_CR32","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1172\/JCI69830","volume":"123","author":"W Grossman","year":"2013","unstructured":"Grossman W, Paulus WJ. Myocardial stress and hypertrophy: a complex interface between biophysics and cardiac remodeling. J Clin Invest. 2013;123(9):3701\u20133.","journal-title":"J Clin Invest"},{"issue":"6A","key":"2509_CR33","doi-asserted-by":"publisher","first-page":"11G","DOI":"10.1016\/j.amjcard.2005.07.016","volume":"96","author":"M Gheorghiade","year":"2005","unstructured":"Gheorghiade M, De Luca L, Fonarow GC, Filippatos G, Metra M, Francis GS. Pathophysiologic targets in the early phase of acute heart failure syndromes. Am J Cardiol. 2005;96(6A):11G-G17.","journal-title":"Am J Cardiol"},{"key":"2509_CR34","doi-asserted-by":"publisher","first-page":"908976","DOI":"10.3389\/fgene.2022.908976","volume":"13","author":"L Li","year":"2022","unstructured":"Li L, Xu N, Liu J, Chen Z, Liu X, Wang J. M6A methylation in cardiovascular diseases: from mechanisms to therapeutic potential. Front Genet. 2022;13:908976.","journal-title":"Front Genet"},{"issue":"1","key":"2509_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41392-021-00699-w","volume":"6","author":"B Zhang","year":"2021","unstructured":"Zhang B, Jiang H, Wu J, Cai Y, Dong Z, Zhao Y, et al. M6A demethylase FTO attenuates cardiac dysfunction by regulating glucose uptake and glycolysis in mice with pressure overload-induced heart failure. Signal Transduct Target Ther. 2021;6(1):377.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2509_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00395-023-00986-3","volume":"118","author":"M Sopic","year":"2023","unstructured":"Sopic M, Robinson EL, Emanueli C, Srivastava P, Angione C, Gaetano C, et al. Integration of epigenetic regulatory mechanisms in heart failure. Basic Res Cardiol. 2023;118(1):16.","journal-title":"Basic Res Cardiol"},{"issue":"3","key":"2509_CR37","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.1080\/21655979.2022.2030572","volume":"13","author":"WL Ke","year":"2022","unstructured":"Ke WL, Huang ZW, Peng CL, Ke YP. M(6)A demethylase FTO regulates the apoptosis and inflammation of cardiomyocytes via YAP1 in ischemia-reperfusion injury. Bioengineered. 2022;13(3):5443\u201352.","journal-title":"Bioengineered"},{"issue":"5","key":"2509_CR38","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1007\/s11010-021-04069-6","volume":"476","author":"W Shen","year":"2021","unstructured":"Shen W, Li H, Su H, Chen K, Yan J. FTO overexpression inhibits apoptosis of hypoxia\/reoxygenation-treated myocardial cells by regulating m6A modification of Mhrt. Mol Cell Biochem. 2021;476(5):2171\u20139.","journal-title":"Mol Cell Biochem"},{"issue":"7 Pt B","key":"2509_CR39","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.bbamcr.2016.01.003","volume":"1863","author":"L Xu","year":"2016","unstructured":"Xu L, Brink M. mTOR, cardiomyocytes and inflammation in cardiac hypertrophy. Biochim Biophys Acta. 2016;1863(7 Pt B):1894\u2013903.","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"2509_CR40","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1172\/JCI43008","volume":"120","author":"D Zhang","year":"2010","unstructured":"Zhang D, Contu R, Latronico MV, Zhang J, Rizzi R, Catalucci D, et al. MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J Clin Invest. 2010;120(8):2805\u201316.","journal-title":"J Clin Invest"},{"issue":"1","key":"2509_CR41","doi-asserted-by":"publisher","first-page":"e54221","DOI":"10.1371\/journal.pone.0054221","volume":"8","author":"Y Zhu","year":"2013","unstructured":"Zhu Y, Pires KM, Whitehead KJ, Olsen CD, Wayment B, Zhang YC, et al. Mechanistic target of rapamycin (Mtor) is essential for murine embryonic heart development and growth. PLoS One. 2013;8(1):e54221.","journal-title":"PLoS One"},{"issue":"25","key":"2509_CR42","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1016\/j.jacc.2009.08.031","volume":"54","author":"SJ Buss","year":"2009","unstructured":"Buss SJ, Muenz S, Riffel JH, Malekar P, Hagenmueller M, Weiss CS, et al. Beneficial effects of mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction. J Am Coll Cardiol. 2009;54(25):2435\u201346.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2509_CR43","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/acel.12109","volume":"12","author":"JM Flynn","year":"2013","unstructured":"Flynn JM, O\u2019Leary MN, Zambataro CA, Academia EC, Presley MP, Garrett BJ, et al. Late-life rapamycin treatment reverses age-related heart dysfunction. Aging Cell. 2013;12(5):851\u201362.","journal-title":"Aging Cell"},{"issue":"19","key":"2509_CR44","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1161\/CIRCULATIONAHA.113.003638","volume":"128","author":"M Volkers","year":"2013","unstructured":"Volkers M, Konstandin MH, Doroudgar S, Toko H, Quijada P, Din S, et al. Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage. Circulation. 2013;128(19):2132\u201344.","journal-title":"Circulation"},{"issue":"6","key":"2509_CR45","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.ajpath.2013.02.012","volume":"182","author":"X Wu","year":"2013","unstructured":"Wu X, Cao Y, Nie J, Liu H, Lu S, Hu X, et al. Genetic and pharmacological inhibition of Rheb1-mTORC1 signaling exerts cardioprotection against adverse cardiac remodeling in mice. Am J Pathol. 2013;182(6):2005\u201314.","journal-title":"Am J Pathol"},{"issue":"1","key":"2509_CR46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/cells8010018","volume":"8","author":"F Boutouja","year":"2019","unstructured":"Boutouja F, Stiehm CM, Platta HW. mTOR: a cellular regulator interface in health and disease. Cells. 2019;8(1):18.","journal-title":"Cells"},{"issue":"4","key":"2509_CR47","doi-asserted-by":"publisher","first-page":"e19237","DOI":"10.1371\/journal.pone.0019237","volume":"6","author":"AG Rajapakse","year":"2011","unstructured":"Rajapakse AG, Yepuri G, Carvas JM, Stein S, Matter CM, Scerri I, et al. Hyperactive S6K1 mediates oxidative stress and endothelial dysfunction in aging: inhibition by resveratrol. PLoS One. 2011;6(4):e19237.","journal-title":"PLoS One"},{"issue":"3","key":"2509_CR48","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1172\/JCI44972","volume":"121","author":"TM Marin","year":"2011","unstructured":"Marin TM, Keith K, Davies B, Conner DA, Guha P, Kalaitzidis D, et al. Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation. J Clin Invest. 2011;121(3):1026\u201343.","journal-title":"J Clin Invest"},{"issue":"2","key":"2509_CR49","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/cvr\/cvab033","volume":"118","author":"S Sciarretta","year":"2022","unstructured":"Sciarretta S, Forte M, Frati G, Sadoshima J. The complex network of mTOR signalling in the heart. Cardiovasc Res. 2022;118(2):424\u201339.","journal-title":"Cardiovasc Res"},{"issue":"40","key":"2509_CR50","doi-asserted-by":"publisher","first-page":"5339","DOI":"10.1038\/onc.2008.261","volume":"27","author":"Y Takagi","year":"2008","unstructured":"Takagi Y, Kobayashi T, Shiono M, Wang L, Piao X, Sun G, et al. Interaction of folliculin (Birt-Hogg-Dube gene product) with a novel Fnip1-like (FnipL\/Fnip2) protein. Oncogene. 2008;27(40):5339\u201347.","journal-title":"Oncogene"},{"issue":"27","key":"2509_CR51","doi-asserted-by":"publisher","first-page":"20036","DOI":"10.1074\/jbc.M702376200","volume":"282","author":"L Wang","year":"2007","unstructured":"Wang L, Harris TE, Roth RA, Lawrence JC Jr. PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding. J Biol Chem. 2007;282(27):20036\u201344.","journal-title":"J Biol Chem"},{"key":"2509_CR52","doi-asserted-by":"crossref","unstructured":"Feng S, Qiu G, Yang L, Feng L, Fan X, Ren F, et al. Omeprazole improves chemosensitivity of gastric cancer cells by m6A demethylase FTO-mediated activation of mTORC1 and DDIT3 up-regulation. Biosci Rep. 2021;41(1):BSR20200842.","DOI":"10.1042\/BSR20200842"},{"issue":"22","key":"2509_CR53","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1038\/s41388-021-01820-7","volume":"40","author":"F Wang","year":"2021","unstructured":"Wang F, Liao Y, Zhang M, Zhu Y, Wang W, Cai H, et al. N6-methyladenosine demethyltransferase FTO-mediated autophagy in malignant development of oral squamous cell carcinoma. Oncogene. 2021;40(22):3885\u201398.","journal-title":"Oncogene"},{"issue":"9","key":"2509_CR54","doi-asserted-by":"publisher","first-page":"153042","DOI":"10.1016\/j.prp.2020.153042","volume":"216","author":"L Zhao","year":"2020","unstructured":"Zhao L, Kong X, Zhong W, Wang Y, Li P. FTO accelerates ovarian cancer cell growth by promoting proliferation, inhibiting apoptosis, and activating autophagy. Pathol Res Pract. 2020;216(9):153042.","journal-title":"Pathol Res Pract"},{"issue":"9","key":"2509_CR55","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/s41422-018-0069-8","volume":"28","author":"S Jin","year":"2018","unstructured":"Jin S, Zhang X, Miao Y, Liang P, Zhu K, She Y, et al. M(6)A RNA modification controls autophagy through upregulating ULK1 protein abundance. Cell Res. 2018;28(9):955\u20137.","journal-title":"Cell Res"},{"issue":"7","key":"2509_CR56","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1080\/15548627.2019.1659617","volume":"16","author":"X Wang","year":"2020","unstructured":"Wang X, Wu R, Liu Y, Zhao Y, Bi Z, Yao Y, et al. M(6)A mRNA methylation controls autophagy and adipogenesis by targeting Atg5 and Atg7. Autophagy. 2020;16(7):1221\u201335.","journal-title":"Autophagy"},{"issue":"1","key":"2509_CR57","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13578-021-00661-x","volume":"11","author":"X Chen","year":"2021","unstructured":"Chen X, Wang J, Tahir M, Zhang F, Ran Y, Liu Z, et al. Current insights into the implications of m6A RNA methylation and autophagy interaction in human diseases. Cell Biosci. 2021;11(1):147.","journal-title":"Cell Biosci"},{"issue":"6036","key":"2509_CR58","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1126\/science.1204592","volume":"332","author":"C Settembre","year":"2011","unstructured":"Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, et al. TFEB links autophagy to lysosomal biogenesis. Science. 2011;332(6036):1429\u201333.","journal-title":"Science"},{"issue":"5","key":"2509_CR59","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.ejca.2013.12.006","volume":"50","author":"A Hollebecque","year":"2014","unstructured":"Hollebecque A, Houede N, Cohen EE, Massard C, Italiano A, Westwood P, et al. A phase Ib trial of LY2584702 tosylate, a p70 S6 inhibitor, in combination with erlotinib or everolimus in patients with solid tumours. Eur J Cancer. 2014;50(5):876\u201384.","journal-title":"Eur J Cancer"},{"issue":"23","key":"2509_CR60","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1111\/bph.15646","volume":"178","author":"JB de la Pena","year":"2021","unstructured":"de la Pena JB, Kunder N, Lou TF, Chase R, Stanowick A, Barragan-Iglesias P, et al. A role for translational regulation by S6 kinase and a downstream target in inflammatory pain. Br J Pharmacol. 2021;178(23):4675\u201390.","journal-title":"Br J Pharmacol"},{"issue":"5","key":"2509_CR61","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1158\/1535-7163.MCT-09-0986","volume":"9","author":"KM Grimshaw","year":"2010","unstructured":"Grimshaw KM, Hunter LJ, Yap TA, Heaton SP, Walton MI, Woodhead SJ, et al. AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growth. Mol Cancer Ther. 2010;9(5):1100\u201310.","journal-title":"Mol Cancer Ther"},{"key":"2509_CR62","doi-asserted-by":"publisher","first-page":"215593","DOI":"10.1016\/j.canlet.2022.215593","volume":"535","author":"M Artemenko","year":"2022","unstructured":"Artemenko M, Zhong SSW, To SKY, Wong AST. P70 S6 kinase as a therapeutic target in cancers: more than just an mTOR effector. Cancer Lett. 2022;535:215593.","journal-title":"Cancer Lett"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02509-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02509-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02509-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:52:17Z","timestamp":1781621537000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-025-02509-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2509"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02509-0","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"522"}}